Advisornet Financial’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,550
Closed -$77K 1792
2020
Q4
$77K Hold
4,550
0.01% 762
2020
Q3
$169K Sell
4,550
-1,600
-26% -$50.1K 0.01% 526
2020
Q2
$140K Sell
6,150
-750
-11% -$16.1K 0.01% 586
2020
Q1
$60K Hold
6,900
0.01% 743
2019
Q4
$102K Hold
6,900
0.01% 673
2019
Q3
$96K Buy
6,900
+2,900
+73% +$31.9K 0.01% 690
2019
Q2
$42K Hold
4,000
﹤0.01% 857
2019
Q1
$42K Hold
4,000
0.01% 781
2018
Q4
$33K Hold
4,000
﹤0.01% 788
2018
Q3
$65K Hold
4,000
0.01% 657
2018
Q2
$44K Hold
4,000
0.01% 741
2018
Q1
$46K Buy
+4,000
New +$48.1K 0.01% 715

Other funds holding MESO

Advisornet Financial's MESO Position: Q1 2021 in Review

Advisornet Financial sold out of Mesoblast (MESO) in Q1 2021, closing a stake of 4,550 shares — an estimated $77K sold.

Advisornet Financial first reported a position in MESO in Q1 2018 and held it in 12 quarters. The position peaked at $169K in Q3 2020. 52 funds tracked by Wall St. Rank hold MESO as of Q1 2021.

  • Advisornet Financial reported no remaining Mesoblast position as of Q1 2021 after selling out during the quarter.
  • Advisornet Financial sold 4,550 Mesoblast shares in Q1 2021, an estimated $77K.
  • Advisornet Financial first reported a position in Mesoblast in Q1 2018 and held it in 12 quarters.
  • Advisornet Financial's Mesoblast position peaked at $169K in Q3 2020.
  • 52 funds tracked by Wall St. Rank held Mesoblast as of Q1 2021.

Based on Advisornet Financial's 13F filing for Q1 2021, filed 14 Apr 2021.